CLPT CIK: 1285550

ClearPoint Neuro, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
61.9
FY22:
51.2
FY23:
36.2
FY24:
33.4
FY25:
63.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.69
FY22:
4.31
FY23:
6.49
FY24:
5.83
FY25:
34.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
65.6
FY22:
55.5
FY23:
42.7
FY24:
39.2
FY25:
97.7

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.75
FY22:
6.79
FY23:
7.43
FY24:
10.4
FY25:
10.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.0
FY22:
11.8
FY23:
14.1
FY24:
3.45
FY25:
59.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
48.8
FY22:
36.9
FY23:
21.2
FY24:
25.4
FY25:
28.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
65.6
FY22:
55.5
FY23:
42.7
FY24:
39.2
FY25:
97.7

All amounts in millions USD Data source:SEC EDGAR